The stock of ReNeuron Group Plc (LON:RENE) is a huge mover today! The stock decreased 5.00% or GBX 0.12 on November 7, hitting GBX 2.38. About 1.96M shares traded hands or 10.73% up from the average. ReNeuron Group Plc (LON:RENE) has declined 20.83% since April 7, 2016 and is downtrending. It has underperformed by 22.79% the S&P500.
The move comes after 7 months negative chart setup for the GBX 78.76 million company. It was reported on Nov, 7 by Barchart.com. We have GBX 2.05 PT which if reached, will make LON:RENE worth GBX 11.03 million less.
More recent ReNeuron Group Plc (LON:RENE) news were published by: Uk.Finance.Yahoo.com which released: “ReNeuron Group plc (RENE.L)” on March 29, 2014. Also Fool.Co.Uk published the news titled: “Is ReNeuron Group Plc The Perfect Partner For BTG plc And Shire PLC In Your …” on June 22, 2015. Fool.Co.Uk‘s news article titled: “Should You Invest In Vodafone Group plc, ReNeuron Group Plc Or Zotefoams plc?” with publication date: July 10, 2015 was also an interesting one.
ReNeuron Group plc is a clinical-stage company. The company has a market cap of 78.76 million GBP. The Company, through its subsidiaries, is engaged in researching and developing cell therapies. It currently has negative earnings. The Company’s products are allogeneic.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.